Atlas Trials

Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes

RecordFirmDate
Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant (NCT03537599)Sumithira Vasu2020-01-10
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant (NCT03128359)City of Hope Medical Center2017-05-30
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent (NCT03146871)University of Southern California2017-04-20
Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed (NCT02935361)University of Southern California2016-11-02

Track Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes automatically

Every clearance here is in the API, with alerts when new ones post.